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Summary
Structural variants (SVs) are implicated in numerous diseases and make up the majority of varying 
nucleotides among human genomes. Here we describe an integrated set of eight SV classes 
comprising both balanced and unbalanced variants, which we constructed using short-read DNA 
sequencing data and statistically phased onto haplotype-blocks in 26 human populations. 
Analyzing this set, we identify numerous gene-intersecting SVs exhibiting population 
stratification and describe naturally occurring homozygous gene knockouts suggesting the 
dispensability of a variety of human genes. We demonstrate that SVs are enriched on haplotypes 
identified by genome-wide association studies and exhibit enrichment for expression quantitative 
trait loci. Additionally, we uncover appreciable levels of SV complexity at different scales, 
including genic loci subject to clusters of repeated rearrangement and complex SVs with multiple 
breakpoints likely formed through individual mutational events. Our catalog will enhance future 
studies into SV demography, functional impact and disease association.
Introduction
SVs, including deletions, insertions, duplications and inversions, account for most varying 
base pairs (bp) among individual human genomes1. Numerous studies have implicated SVs 
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in human health with associated phenotypes ranging from cognitive disabilities to 
predispositions to obesity, cancer and other maladies1,2. Discovery and genotyping of these 
variants remains challenging, however, since SVs are prone to arise in repetitive regions and 
internal SV structures can be complex3. This has created challenges for genome-wide 
association studies (GWAS)4,5. Despite recent methodological and technological 
advances6-9, efforts to perform discovery, genotyping, and statistical haplotype-block 
integration of all major SV classes have so far been lacking. Earlier SV surveys depended on 
microarrays10 as well as genomic and clone-based approaches limited to a small number of 
samples11-15. More recently, short-read DNA sequencing data from the initial phases of the 
1000 Genomes Project8,9 enabled us to construct sets of SVs, genotyped across populations, 
with enhanced size and breakpoint resolution6,7. Previous 1000 Genomes Project SV set 
releases, however, encompassed fewer individuals and were largely6 or entirely8 limited to 
deletions, in spite of the relevance of other SV classes to human genetics1,2,4.
The objective of the Structural Variation Analysis Group has been to discover and genotype 
major classes of SVs (defined as DNA variants ≥50 bp) in diverse populations and to 
generate a statistically phased reference panel with these SVs. Here we report an integrated 
map of 68,818 SVs in unrelated individuals with ancestry from 26 populations 
(Supplementary Table 1). We constructed this resource by analyzing 1000 Genomes Project 
phase 3 whole-genome sequencing (WGS) data16 along with data from orthogonal 
techniques, including long-read single-molecule sequencing (Supplementary Table 2), to 
characterize hitherto unresolved SV classes. Our study emphasizes the population diversity 
of SVs, quantifies their functional impact, and highlights previously understudied SV classes 
including inversions exhibiting marked sequence complexity.
Results
Construction of our phase 3 SV release
We mapped Illumina WGS data (~100 bp reads, mean 7.4-fold coverage) from 2,504 
individuals onto an amended version8 of the GRCh37 reference assembly using two 
independent mapping algorithms—BWA17 and mrsFAST18—and performed SV discovery 
and genotyping using an ensemble of nine different algorithms (ED Figure 1 and 
Supplementary Notes). We applied several orthogonal experimental platforms for SV set 
assessment, refinement and characterization (Supplementary Table 2) and to calculate the 
False Discovery Rate (FDR) for each SV class (Table 1). Callset refinements facilitated 
through long-read sequencing enabled us to incorporate a number of additional SVs into our 
callset, including an additional 698 inversions and 9,132 small (<1 kbp) deletions, compared 
to the SV set released with the 1000 Genomes Project marker paper16. As a result, our 
callset differs slightly relative to the marker paper’s SV set16 (see Supplementary Table 2). 
We merged individual callsets to construct our unified release (Table 1), comprising 42,279 
biallelic deletions, 6,025 biallelic duplications, 2,929 mCNVs (multi allelic copy-number 
variants), 786 inversions, 168 nuclear mitochondrial insertions (NUMTs), and 16,631 mobile 
element insertions (MEIs— including 12,748, 3,048 and 835 insertions of Alu, L1 and SVA 
(SINE-R, VNTR and Alu composite) elements, respectively).
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SV non-reference genotype concordance estimates ranged from ~98% for biallelic deletions 
and MEI classes to ~94% for biallelic duplications. 60% of SVs were novel with respect to 
the Database of Genomic Variants (DGV)19 (50% reciprocal overlap criterion, Figure 1a), 
whereby 71% of SVs (50% reciprocal overlap) and 60% of collapsed copy-number variable 
regions (CNVRs, 1 bp overlap) were novel compared to previous 1000 Genomes Project 
releases6,8, reflecting methodological improvements and inclusion of additional populations. 
Novel SVs showed enrichment for rare sites, which we detected down to an autosomal allele 
count of ‘1’. And while variations in FDR estimates were evident with SV size and VAF 
(variant allele frequency), we consistently estimated the FDR at ≤5.4% when stratifying 
deletions and duplications by size and frequency, including for rare SVs with VAF<0.1% 
(ED Figures 1, 2). A comparison with deep-coverage Complete Genomics (CG) sequencing 
data indicated an overall sensitivity of 88% for deletions and 65% for duplications, with the 
false negatives driven largely by the relatively lowered sensitivity for ascertaining small SVs 
in Illumina sequencing data (Figure 1b, ED Figure 3). The average per-individual sensitivity 
was similar for deletions (89%) and slightly lower for duplications (50%). For MEI classes, 
estimated sensitivities ranged from 83%–96% (Table 1) compared to the 1000 Genomes 
Project pilot phase where a different MEI detection tool was used20. For inversions, we 
estimated an overall sensitivity of 32% based on variants with a positive validation status 
recorded in the InvFEST database21, with an increased sensitivity of 67% for inversions <5 
kbp in size.
We performed breakpoint assembly using pooled Illumina WGS and Pacific Biosciences 
(PacBio) sequencing data22, and additionally performed split-read analysis23 of short reads, 
to resolve the fine-resolution breakpoint structure of 37,250 SVs (29,954 deletions, 357 
tandem duplications, 6,919 MEIs, and 20 inversions; Supplementary Table 3). Breakpoint 
assemblies showed a mean boundary precision of 0–15 bp for all SV types with the 
exception of inversions and duplications for which we achieved mean precision estimates of 
32 bp and 683 bp, respectively (Table 1, Figure 1c).
Population genetic properties of SVs
We explored the population genetic properties of SVs among five continental groups—
Africa (AFR), the Americas (AMR), East Asia (EAS), Europe (EUR) and South Asia (SAS). 
The bulk of SVs occur at low frequency (65% exhibit VAF<0.2%) consistent amongst 
individual SV classes (ED Figures 2, 3). While rare SVs are typically specific to individual 
continental groups, at VAF≥2% nearly all SVs are shared across continents (Figure 1d, ED 
Figure 3). Notably, we identified 1,075 SVs with VAF>50% (889 biallelic deletions, 2 
biallelic duplications, 90 mCNVs, 88 MEIs and 6 inversions) encompassing 5 Mbp, sites of 
interest for future updates to the human reference genome. We estimated the mutation rate 
for each SV class using Waterson’s estimator of θ, for example, ascertaining a mutation rate 
of 0.113 deletions per haploid genome generation, a threefold higher estimate compared 
with previous reports10,24, likely due to our increased power for detecting variants <5 kbp 
(Supplementary Note).
We found that 73% of SVs with >1% VAF and 68% of rarer SVs (VAF>0.1%) are in linkage 
disequilibrium (LD) with nearby single nucleotide polymorphisms (SNPs) (r2>0.6); 
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however, the proportion of variants in LD highly depends on the SV class (Figure 1e, ED 
Figure 4). For example, only 44% of all biallelic duplications with VAF>0.1% were in LD 
with a nearby SNP (r^2>0.6), in agreement with previous findings10,25,26. Notably, we 
observed a striking depletion of biallelic duplications amongst common SVs (P<2×10−16, 
KS-test; ED Figure 5) with most common duplications classified as multi-allelic SVs (i.e., 
mCNVs). This behavior suggests extensive recurrence of SVs at duplication sites consistent 
with what was recently observed in a smaller cohort of 849 individuals27. These LD 
characteristics suggest duplications are currently under-ascertained for disease associations 
using tag-SNP-based approaches.
Based on our haplotype-resolved SV catalog, we observed that individuals of African 
ancestry exhibit, on average, 27% more heterozygous deletions than individuals from other 
populations (mean of 1,705 vs. 1,342) consistent with SNPs28 (ED Figure 5). The relative 
proportion of deletion- versus SNP-affected sequence, however, showed a 13% excess in 
non-African compared to African populations (ratio 1.64 vs. 1.45). Principal component 
analyses with different SV classes generally recapitulated continental population structure 
and admixture (ED Figure 6 and Supplementary Note). Our analysis further allowed us to 
identify a catalog of 6,495 ancestry-informative MEI markers of potential value to 
population genetics history and forensics research (ED Figure 5, Supplementary Table 4).
Since population stratification can be used as a signature to detect adaptive selection, we 
additionally identified SVs varying in VAF amongst different populations. For each SV site 
we calculated a Vst statistic, a measure highly correlated with Fst (the fixation index)29 that 
can be applied to assess population stratification of biallelic and multi-allelic SVs29. We 
observed 1,434 highly stratified SVs (>0.2 Vst, corresponding to 2.9 standard deviations 
(s.d.) from the mean; Supplementary Table 5) among which 578 intersected gene coding 
sequences (CDSs). Among these were several SVs associated with regions previously 
reported to be under positive selection, such as KANSL1 mCNVs (ED Figure 6) that tag a 
European-enriched inversion polymorphism associated with increased fecundity30. Most of 
the population-stratified sites, however, have not been previously described and are, thus, 
potential targets for future investigation of SVs undergoing adaptive selection or genetic 
drift. These include, for example, a 14.5 kbp intronic duplication of HERC2 enriched in East 
Asians (Vst=0.62 EAS-EUR).
Functional impact of SVs
We analyzed the intersection of deletions binned by VAF with various classes of genic and 
intergenic functional elements (Figure 2a, ED Figure 7). The CDSs, untranslated regions 
(UTRs) and introns of genes, in addition to ENCODE31 transcription factor binding sites 
and ultrasensitive noncoding regions, showed a significant depletion (P<0.001; permutation 
testing in each VAF bin) compared to a random background model. In general, these 
elements are more depleted (in terms of fold change) in common VAF bins compared to 
rarer deletion alleles in keeping with purifying10 (or in some cases background32) selection. 
Genes more intolerant to mutation (as measured from SNP diversity, residual variation 
intolerance score (RVIS)33 <20) exhibited the most pronounced depletion (P<0.001; 
permutation testing between pairs of RVIS-score categories). All other SV classes exhibited 
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similar signatures of selection; when compared to deletions these depletions were, however, 
more attenuated (Figure 2b, ED Figure 7). Additional assessment of the site frequency 
spectrum showed that as deletion sizes increase these SVs become more rare (p<2.2e-16; 
linear model, F-test), evidence of purifying selection against events more likely intersecting 
functional elements. Duplications, by comparison, did not exhibit such trend, consistent with 
reduced selective constraints (Supplementary Note).
We additionally analyzed 5,819 homozygous deletions to search for gene knockouts 
naturally occurring in human populations. Among these we identified 240 genes 
(corresponding to 204 individual deletion sites), which based on the observation of 
homozygous losses in normal individuals appear “dispensable” (Supplementary Table 6). 
Most of the underlying deletions were found in more than one human population, and for 
only one (0.5%) we observed evidence for the putative involvement of uniparental disomy in 
the homozygosity (Supplementary Note). The majority (>80%) of these homozygous gene 
losses were novel compared to a previous analysis based on DGV variants19, or recent 
clinical genomics studies (Supplementary Note). As expected, genes affected by 
homozygous loss were not highly conserved and were relatively tolerant to other forms of 
genetic variation (RVIS=0.74 compared to OMIM disease genes showing RVIS=0.43; 
p=9.4e-25; Mann-Whitney test). Moreover, the set was functionally enriched for 
glycoproteins (Benjamini Hochberg corrected p-value=1.6×10−3, EASE [Expression 
Analysis Systematic Explorer] score) and genes harboring immunoglobulin domains 
(Benjamini Hochberg corrected p-value=1.0×10−5, EASE score).
We next quantified the functional impact of SVs using expression quantitative trait loci 
(eQTL) associations as a surrogate34,35. Based on transcriptome data from lymphoblastoid 
cell lines derived from 462 individuals36 (the gEUVADIS consortium), we tested 18,969 
expressed protein-coding genes for cis-eQTL associations, considering 1 Mbp candidate 
regions upstream and downstream of CDSs. A joint eQTL analysis using SNPs, InDels and 
SVs with VAF>1% identified 54 eQTLs with a lead SV association (denoted SV-eQTL) and 
9,537 eQTLs with a lead SNP/InDel association (10% FDR). For an additional 166 eQTLs 
with lead associations to SNPs or InDels, we observed SVs in LD (r2>0.5) seven times more 
than when using random variants matched for LD structure, distance to the transcription start 
site, and VAF, suggesting that a larger number of eQTLs are likely impacted by SVs (ED 
Figure 8, Supplementary Table 7). In proportion to the number of variants tested, SV classes 
were up to ~50-fold enriched for SV-eQTLs (p=2.84×10−39, one-sided Fisher’s exact test; 
Supplementary Table 8). Large SVs were associated with increased effect size, for example, 
a twofold increase in effect size for genic SVs >10 kbp versus variants <1 kbp (P=0.0004; t-
test; ED Figure 8). Taken together, although SNPs contribute more eQTLs overall, our 
results suggest SVs have a disproportionate impact on gene expression relative to their 
number.
Among those 220 eQTLs having either an SV-eQTL or an SV in LD with the lead SNP/
InDel, most were due to deletions (55% of associations) followed by mCNVs (19%) 
(Supplementary Table 8). Although SV-eQTLs with the largest effect sizes tended to overlap 
with CDSs, such as for the dual specificity phosphatase 22 (DUSP22) gene (Figure 2c), we 
also observed several expression-associated SVs strictly intersecting upstream noncoding 
Sudmant et al. Page 5
Nature. Author manuscript; available in PMC 2016 April 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
sequences, including an mCNV upstream of ZNF43 (Figure 2d) possibly mediated through 
variation of a cis-regulatory element. We additionally considered the impact of accounting 
for SVs when constructing personalized reference genomes for transcriptome analysis. To 
illustrate this, we considered RNA read alignments for the sample NA12878, comparing the 
standard reference genome with GRCh37-derived personalized references constructed using 
NA12878 SNPs, or using NA12878 SNPs and SVs. Using such an approach, we observed 
marked changes in expression for 525 exons (±10 reads, ≥1-fold change relative to the 
standard reference), 24 of which could be attributed to the inclusion of SVs into the 
personalized reference (Supplementary Table 9).
The relevance of SVs to eQTLs suggests that a number of disease associations previously 
detected by GWAS may be attributable to SVs, which are difficult to assess directly in 
GWAS. To test this hypothesis we compared 12,892 previously reported SNP-based GWAS 
hits to SVs identified in our dataset, identifying 136 candidate SVs in strong LD (r2>0.8) 
with GWAS variants, which represents a 1.5-fold enrichment when compared to a VAF and 
haplotype size-matched background set and a 3-fold enrichment for deletions >20 kbp 
(P=0.004) (Figure 2e and Supplementary Note). Approximately a third of these candidate 
GWAS associations (39) were novel, impacting phenotypes such as colorectal cancer and 
bone mineral density (Supplementary Table 10). Interestingly, 64% of these novel 
associations were mediated by deletions <1 kbp, a size-range for which our study has 
improved power over previous surveys, which more than doubles (from 18 to 40) the 
number of SVs <1 kbp in strong LD with a GWAS lead SNP. Thus, our SV resource could 
facilitate discovery of numerous additional disease-linked SVs.
SV clustering and complexity
Advances in Illumina sequencing towards longer read lengths (~100 bp vs. 36 bp)6 in 
conjunction with the population-level data allowed us to perform an in-depth investigation of 
SV complexity and clustering. We identified 3,163 regions where SVs appeared to cluster 
(>2 SVs mapping within 500 bp; Supplementary Table 11). To reduce redundancy caused by 
multiple overlapping calls per sample, we calculated distinct CNVRs per cluster by merging 
calls per sample and haplotype and then counting the distinct CNVRs produced across 
samples (average 6.4 ± 7.2 CNVRs per cluster). We identified 30 genomic regions with an 
excess of CNVRs (>4 s.d. or >36 CNVRs per cluster). This clustering effect was not 
correlated with segmental duplications (r=0.02) and only partially explained by SNP 
diversity (r=0.15; ED Figure 9). CNVR clusters showed enrichment near late-replicating 
origins (p=0.013, permutation test) and at cytogenically defined ‘fragile’ sites (p=0.0017; 
permutation test). Although the proportion of gene content in regions exhibiting excessive 
SV clustering was significantly reduced when compared to a null distribution (p<0.000001, 
permutation test), 1,881 of 3,163 such regions (59%) intersected one or more genes 
(Supplementary Table 11). This includes a region comprised of 47 SVs (ranking 2nd out of 
the 30 genomic regions with >4 s.d.) encompassing the pregnancy-specific glycoprotein 
gene family (Figure 3a), a set of genes thought to be critically important for maintenance of 
pregnancy37. Other SV clusters associated with genes (e.g., IMMP2L, CHL1 and GRID2) 
have been implicated as potential risk factors for disease, including neurodevelopmental 
disorders38.
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We additionally specifically assessed the complexity of the 29,954 deletions with resolved 
breakpoints and found that 6% (1,822) intersected another deletion with distinct breakpoints. 
A larger fraction (16% or 4,813 of assembled deletion sites) showed the presence of 
additional inserted sequence at deletion breakpoints. We grouped 1,651 deletions with mean 
size of 3.1 kbp and at least 10 bp of additional DNA sequence between the original SV site 
boundaries into five broad classes (Figure 3b, Supplementary Table 12). The most common 
class (N=501, 30.3%), termed Ins with Dup and Del, comprised deletions exhibiting a 
recognizable duplicated sequence interval within the respective inserted sequence. Notably, 
in many cases (N=191) the inserted sequences comprised two or more apparent sequence 
duplications at the deletion boundaries (a class denoted Ins with MultiDup and Del). 
Additional classes commonly observed include Inv and Del (inversion with adjacent 
deletion; N=9) and MultiDel—a class where two or more adjacent deletions are separated by 
at least one sequence “spacer” of up to ~204 bp in length (N=370). However, not all 
complex SVs fit into these classes, with 214 sites forming distinct patterns corresponding to 
multiple classes or exhibiting increased complexity. Template-switching mechanisms could 
explain the notable complexity of these SVs3. Indeed, microhomology patterns were 
typically present between the breakpoints of deletions and the respective boundaries of 
insertion templates at these sites (ED Figure 9) consistent with formation through single 
mutational events (Supplementary Note). Across the complex sites assessed, 871 (53%) 
showed evidence for a local template (≥10 bp match, within 10 kbp), whereas for 41 the 
insertion was presumably templated from a distal region (≥22 bp match, >10 kbp away), 
including 17 sites where the DNA stretch was likely derived from RNA templates 
(Supplementary Table 13).
To further characterize SV breakpoint complexity, we employed two alternative approaches 
that do not rely on low-coverage Illumina read assembly. We first examined 7,804 small 
deletions for breakpoint complexity using split-read analysis23 (Figure 3c) and identified 
664 (median size: 67 bp) exhibiting complexity, 64 of which contained insertions ≥3 bp that 
may be derived from a nearby template (Supplementary Table 14, ED Figure 9). We 
additionally realigned long DNA reads from a single individual (NA12878)22 sequenced by 
high-coverage PacBio (median read length=3.0 kbp) and Moleculo (median=3.2 kbp) single-
molecule WGS around deletions from our release set (Figure 3d). Out of 766 deletions in 
NA12878 investigated with this approach, 62 exhibited complexity showing three to six 
breakpoints (Supplementary Table 12). A deletion of exon 3 of the serine protease inhibitor 
SPINK14, for example, was accompanied by an inversion of an internal segment of the SV 
sequence (Figure 3d panel i). In contrast to the smaller proportion of deletions showing 
breakpoint complexity, the majority of inversions assessed in NA12878 (19/28) exhibited 
multiple breakpoints.
To further explore inversion sequence complexity, we performed a battery of targeted 
analyses, leveraging PacBio resequencing of fosmids (targeting 34 loci), sequencing by 
Oxford Nanopore Minion (60 loci) and PacBio (206 loci) of long-range PCR amplicons, and 
data for 13 loci from another sample (CHM1) sequenced by high-coverage PacBio WGS14. 
Altogether we verified and further characterized 229 inversion sites, 208 using long-read 
data and 21 by PCR (Supplementary Table 15) increasing the number of known validated 
inversions21 by >2.5-fold. Remarkably, only 20% of all sequenced inversions characterized 
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in this manner were “simple” (termed Simple Inv), exhibiting two breakpoints (Figure 3e), 
including a 2 kbp inversion on chromosome 4 intersecting a regulatory exon of the Ras 
homolog family member RHOH (Figure 3d panel iv). The majority of inversions (54%) 
corresponded to inverted duplications (Inverted Dup; Figure 3d panel iii). In nearly all cases, 
these involved duplicated stretches <1 kbp inserted within 5 kbp of the alternate copy, 
suggesting a common mechanism of SV formation (ED Figure 10). The remaining 
inversions comprised Inv and Del events (14%), MultiDel events exhibiting inverted spacers 
(7%), and more highly complex sites (5%; Figure 3d panel ii). The appreciable inversion 
complexity uncovered here is most likely due to a mutational process forming complex SVs, 
potentially involving DNA replication errors3, rather than due to recurrent rearrangement, as 
our analyses failed to detect corresponding intermediate events in 1000 Genomes Project 
samples.
Discussion
We present the most comprehensive set of human SVs to date as an integrated resource for 
future disease and population genetics studies. We estimate individuals harbor a median of 
18.4 Mbp of SVs per diploid genome, an excess contributed to a large extent by mCNVs 
(11.3 Mbp) and biallelic deletions (5.6 Mbp; Table 1). When collapsing mCNV sites 
carrying multiple copies as well as homozygous SVs onto the haploid reference assembly, a 
median of 8.9 Mbp of sequence are affected by SVs, compared to 3.6 Mbp for SNPs. 
Furthermore, 37,250 SVs have mapped breakpoints amounting to >113 Mbp of SV sequence 
resolved at the nucleotide-level. By mining homozygous deletions we identified over two 
hundred nonessential human genes, a set enriched for immunoglobulin domains that hence 
may reflect variation in the immune repertoire underlying inter-individual differences in 
disease susceptibility.
We demonstrate that SV classes are disproportionally enriched (by up to ~50-fold) for SV-
eQTLs, although only 220 SVs were either found as lead eQTL association or in high LD 
with the respective lead SNP. While this corresponds to proportionally fewer associations 
relative to SNPs compared to a prior estimate based on array technology34, this may be 
explained by the reliance of this prior estimate on bacterial artificial chromosome arrays, 
which ascertain large SVs (>50 kbp) that associate with strong effect size, as well as by the 
relative scarcity of SNPs tested in an earlier study34 (HapMap Phase I)39. We further expand 
the number of candidate SVs in strong LD with GWAS hits by ~30% (39/136 novel 
associations implicating SVs as candidates) and find that GWAS haplotypes are enriched up 
to threefold for common SVs, which emphasizes the relevance of ascertaining SVs in 
disease studies. The large number of novel SVs smaller than 1 kbp in length associated with 
previously reported GWAS hits highlights the importance of increasing sensitivity for SV 
detection and genotyping at this size range. Additionally, the large number of rare SVs 
captured by our resource may be of value for disease association studies investigating rare 
variants.
Our deep population survey has identified hotspots of SV mutation that cannot be accounted 
for by deep coalescence or segmental duplication content. We describe hitherto undescribed 
patterns of SV complexity, particularly for inversions. These patterns indicate that other 
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more complex mutational processes outside of non-allelic homologous recombination, 
retrotransposition, and non-homologous end-joining played an important role in shaping our 
genome. In spite of this, it remains difficult to fully disentangle the contributions of SV 
mutation rates and selective forces to the observed variant clustering. The findings presented 
here leveraged substantial recent technological advances, including increases in Illumina 
read length and developments in long-read DNA technologies. SV discovery remains a 
challenge nonetheless, and the full complexity and spectrum of SV is not yet understood. 
Our analyses, for example, are largely based on 7.4-fold Illumina WGS and, thus, are 
underpowered to capture much of the complexity of variation, including SVs in repetitive 
regions, non-reference insertions, and short SVs at the boundaries of the detection limits of 
read-depth and paired-end-based SV discovery4. Furthermore, while many SVs in our callset 
are statistically phased, the diploid nature of the genome is non-optimally captured by 
current analysis approaches, which mostly rely on mapping to a haploid reference. We 
envision that in the future, the use of technology allowing substantial increases in read 
lengths over the current state-of-the-art will enable genomic analyses of truly diploid 
sequences to facilitate targeting these additional layers of genomic complexity. Until this is 
realized, our SV set represents an invaluable resource for the construction and analysis of 
personalized genomes.
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Extended Data
ED Figure 1. 
(A) Approach used for constructing our SV release set. (B) Intensity rank sum (IRS) 
validation results for deletions in different size bins. (C) IRS validation results for deletions 
in variant allele frequency (VAF) bins. (D) IRS results for duplications in different size bins. 
(E) IRS validation results for duplications in VAF bins. Based on Affymetrix SNP6 array 
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probes, the IRS FDR for all SV length and VAF bins was ≤5.4%, requiring at least 100 SVs 
per bin with an IRS assigned p-value.
ED Figure 2. 
This figure shows the number of SV sites in our phase 3 release relative to allele frequency 
expressed in terms of allele count. SVs down to an allele count of 1 (corresponding to 
VAF=0.0002) are represented in our phase 3 SV set (with the exception of mCNVs, denoted 
‘CNV’ in this figure, which are defined as sites of multi-allelic variation thus requiring allele 
count ≥2 – hence no mCNV sites are ascertained for allele count = 1).
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ED Figure 3. 
(A) Variants ascertained in the 1000GP pilot phase (Mills et al., light gray) as well as the 
recent publication of SVs ascertained by PacBio sequencing in the CHM1 genome 
(Chaisson et al., gray) are displayed for comparison in this SV size distribution figure (INS, 
used as abbreviation for MEIs and NUMTs in this display item). (B) Population distribution 
of SV allele sharing across continental groups for different SV classes. (C) Cumulative 
distributions of the number of events as a function of size by SV class.
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ED Figure 4. 
(A) LD properties of deletions, broken down by continental group and shown as a function 
of VAF. (B) LD properties of duplications. (C) LD properties of Alu, L1 and SVA mobile 
element insertions. (D) LD properties of inversions (with breakdown for two independent 
inversion sets generated with our inversion discovery algorithm Delly; i.e., CINV=one-sided 
inversions with support for one breakpoint; INV=two-sided inversions with support for both 
breakpoints; these two sets are combined into the joint phase3 SV group inversion set).
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ED Figure 5. 
(A) Deletion heterozygosity and homozygosity among human populations for a subset of 
high-confidence deletions. Populations from the African continental group (AFR) exhibit the 
highest levels of heterozygosity and thus diversity among humans, but show the overall 
lowest level of deletion homozygosity among all continental groups. By comparison, East 
Asian populations exhibited the lowest levels of deletion heterozygosity and the highest 
levels of homozygosity. (Het., heterozygous. Hom., homozygous.) (B) VAF distribution of 
major SV classes. Bi-allelic duplications represent a notable outlier, showing a striking 
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depletion of common alleles, which can be explained by the preponderance of genomic sites 
of duplication to undergo recurrent rearrangement (see main text). As a consequence, most 
common duplications are classified as multi-allelic variants (i.e. mCNVs). (C) The number 
of base pairs (bp) differing among individuals within and between continental groups for 
deletions (upper panel) and SNPs (middle panel) contrasted with the ratio of deletion bp 
differences to SNP bp differences (deletion bp/SNP bp) among groups (lower panel). Non-
African groups exhibit a higher deletion bp/SNP bp compared to Africans. (D) Neighbor-
joining tree of populations constructed from MEIs (homoplasy-free markers) to provide a 
(simplified) view of population ancestry. The tree is labeled with the number of lineage-
specific MEIs (Alu:L1:SVA). (E) Classification of ancestry in AFR/AMR and AMR 
admixed populations using homoplasy-free ancestry informative MEI markers. Color usage 
follows the same scheme as in Fig. 1d, except in the case of AFR individuals, which use 
both the color in Fig. 1d and another color that is unrelated to any other figure to indicate 
additional substructure within this group.
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ED Figure 6. 
(A) PCA plot of principal components 1 and 2 for deletions. (B) PCA plot of principal 
components 3 and 4 for deletions. (C) PCA plot of principal components 1 and 2 for MEIs. 
(D) PCA plot of principal components 3 and 4 for MEIs. (E) The five most highly 
population-stratified deletions intersecting protein-coding genes based on Vst. (F) The five 
most highly population-stratified duplications and multi-allelic copy number variants 
(mCNVs) intersecting protein-coding genes based on Vst. For abbreviations, see 
Supplementary Table 1.
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ED Figure 7. 
(A) Shadow figure of Figure 2a. Overlap enrichment analysis of deletions (with resolved 
breakpoints) versus genomic elements, using partial overlap statistic, deletions categorized 
into VAF bins. (B) Similar to (A). The only difference is that engulf overlap statistic is used 
instead of partial overlap statistic. Engulf overlap statistic is the count of genomic elements 
(e.g. CDS) that are fully imbedded in at least one SV interval (e.g. deletions). *no element 
intersected observed within dataset. (C) Similar to (A) and (B), with the enrichment/
depletion analysis pursued for common SNPs as well as more rare single nucleotide 
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polymorphisms/variants (SNVs). Common SNV alleles show the highest levels of depletion 
for investigated genomic elements. (D) Overlap enrichment analysis of various SV types 
versus genomic elements, using partial overlap statistic.
ED Figure 8. 
(A) SV-centric eQTL analysis of coding SVs. Shown is the proportion of coding SVs that 
are eQTLs as a function of the minimum VAF and the expression quartile. (B) Total number 
of coding SVs for corresponding filters. Common SVs (VAF>0.2) in highly expressed genes 
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(>75% quantile) are very likely to correspond to SV-eQTLs (54%, see also Supplementary 
Table 8). (C) For all genes with significant eQTLs (FDR<10%), shown are raw p-values 
considering only SNPs (x-axes) or only SVs (y-axes). Genes with (strict lead) SV-eQTLs are 
shown in red. Genes with a SNP lead eQTL that is in linkage with an SV (r^2>0.5) are 
shown in orange. SNP lead eQTLs without an SV in LD are shown in blue. (D) Relative 
eQTL effect sizes for genetic and intergenic SV eQTLs (N=239) either with an SV-eQTL or 
an LD tagged SV (in log abundance scale). Shown are regression trends for both genic and 
intergenic SV eQTls. For genetic eQTLs, a clear relationship between SV effect size is 
found. For example, genic SVs >10kb have 3-fold larger effect sizes compared to genic SVs 
< 1kb; P=0.004; t-test.
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ED Figure 9. 
Extensive clustering of recurrent SVs into CNVRs appears unrelated to the extent of 
segmental duplications (A) and is only partially correlating with SNP diversity (B) and GC 
content (C). Breakdown of SV mechanism classifications based on criteria from two earlier 
studies (Conrad et al. and Mills et al.). Shown are results for deletions with nucleotide 
resolved breakpoints. BreakSeq was used for mechanism inference. (D) 1KG_P3: 
Breakdown for our 1000GP phase 3 SV callset using classification criteria from Mills et al. 
(E) Conrad_2010: summary of mechanism classification results published in Conrad et al. 
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(F) Mills_2011: summary of mechanism classification results published in Mills et al. (G) 
1KG_P3_Conrad: Breakdown for our 1000GP phase 3 SV callset using classification criteria 
from Conrad et al. Mechanism classification was pursued using four different categories: 
Blue=non-allelic homologous recombination (NAHR); green=mobile elements inserted into 
the reference genomes (appearing deleted in this analysis); red=nonhomology-based 
rearrangement mechanisms (NHR), such as NHEJ, microhomology-mediated end-joining 
and microhomology-mediated break-induced replication (involving blunt-ended deletion 
breakpoints or breakpoints with microhomoloy); purple=expansion or shrinkage of variable 
numbers of tandem repeats (VNTRs). TEI, transposable element insertion (equivalent with 
MEI). (H) Distribution of lengths of micro-homology (MH) for complex SVs, measured 
between deletion and corresponding template sites boundaries. Simple deletions, which 
based on BreakSeq were inferred to be formed by a nonhomology-based SV formation 
mechanism, such as NHEJ and microhomology-mediated break-induced replication 
(Supplementary Table 3), are shown as an additional control (here denoted “blunt NH 
deletions”). (I) Origins of inserted sequences in complex deletions inferred by split read 
analysis. This figure depicts examples for each class shown in Supplementary Table 13.
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ED Figure 10. 
Examples for five classifications of inversions verified using PacBio and Minion reads: 
Simple Inversion (A), inv-dup (B), inv-del (C), MultiDel with Inv (here abbreviated as 
inv-2dels) (D) and complex (E). (F) Several further examples of inverted duplications (inv-
dup), the most common form of inversion-associated SV identified in the phase 3 release set. 
The figure is depicting DNA sequence alignment dotplots (same arrangement as in Figure 
3), with the Y-axis referring to PacBio DNA single molecule sequencing reads and the X-
axis referring to the reference genome assembly (hg19). Inverted sequences are highlighted 
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in red. Sequence analysis suggests that these inverted duplications are not typically 
associated with retrotransposition.
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Figure 1. Phase 3 integrated SV callset
a. Novelty based on overlap of our SV set with DGV19 (upper panel i, broken down by SV 
class), of collapsed CNVRs with earlier 1000 Genomes Project releases6,8 (ii) and of our SV 
set with refs6,8 (iii). b. Size distribution of ascertained SVs (bin width is uniform in log-
scale). DEL, biallelic deletion, DUP, biallelic duplication, INV, inversion, INS, non-
reference insertion (including MEIs and NUMTs). c. Breakpoint precision of assembled 
deletions stratified by VAF (split-read caller Pindel23 shown separately). d. SV allele sharing 
across continental groups. f. LD properties of biallelic SV classes.
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Figure 2. SV functional impact
a. Relative enrichment or depletion of genomic elements within breakpoint-resolved 
deletions binned by VAF. TF, transcription factor binding site; nc, noncoding. RVIS range 
from 0–100 (low <20, medium 20–50, high ≥50). *no element intersected. b. Enrichment/
depletion of genomic elements within different SV classes, compared with breakpoint-
resolved deletions. c. Manhattan plot of DUSP22-eQTL. Inset: boxplots of association 
between copy-number genotype and expression. d. Manhattan plot of ZNF43-eQTL. e. 
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Enrichment of SV-containing haplotypes at previously reported GWAS hits (error bars show 
s.e.m.).
Sudmant et al. Page 30
Nature. Author manuscript; available in PMC 2016 April 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 3. SV complexity at different scales
a. PSG locus with clustered SVs. Population copy-number state histograms are shown for 
two example SVs. b. Schemes depicting assembled complex deletions. c. Smaller-scale 
complex deletions identified with Pindel23. Flanking sequences are shown for reference 
(REF) and alternate (ALT) alleles, further to insertions at the breakpoints. Proximal stretches 
matching the insertion are labeled in red (forward) and green (reverse complement). Blue: 
insertions lacking nearby matches. d. Alignment dotplots depicting inversions (inverted 
sequences are in red within each dotplot). Adjacent schemes depict allelic structures for REF 
and ALT. e. Inversion complexity summarized.
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Table 1
Phase 3 extended SV release
FDR estimates are based on intensity rank-sum testing8 using Affymetrix SNP6A and Omni 2.5 arraysO, 
PCRP, as well as long-readL, PCR-free (250 bp-read)D and CGC sequencing (CG-based estimates used 
reciprocal overlaps of 50% and 20% for deletions and duplications, respectively). #,Vestimate by comparing 
MEIs to all calls# or all PCR-validated callsV from20 (estimates for individual MEI classes are in 
Supplementary Table 4). NA*, no previous data available. Differences in deletion and duplication counts are 
driven by size-cutoffs and classification of common duplications as mCNVs27. RRascertained using read-pairs 
or read-depth. SRascertained with split-reads23. Testimated for tandem duplications. †estimated for inversions 
with paired-end support from both breakpoints.
SV
class
No. sites Median size
of SV sites
(bp)
Median
kbp per
Individual
Median
Alleles per
individual
Site
FDR
Biallelic site
breakpoint
precision
(bp)
Genotype
concordance
(non-ref.)
Sensitivity
estimates
Deletion (biallelic) 42,279 2,455 5,615 2,788 2% A
- 4% O
15 (±50)RR
0.7 (±9.5)SR
98% C 88% C
Duplication (biallelic) 6,025 35,890 518 17 1% A
- 4% O
683 (±1350) T 94% C 65% C
mCNV 2,929 19,466 11,346 340 1% A
- 4% O
- NA* NA*
Inversion 786 1,697 78 37 17% L
(9%) P, †
32 (±47) † 96% L 32%
MEI 16,631 297 691 1,218 4% P 0.95 (±5.93) 98% D 83 #
- 96% V
NUMT 168 157 3 5.3 10% P 0.25 (±0.43) N 86.1% P NA*
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